Home
All Products
Chemicals
Compounds and Mixtures
Iron oxide (II,III), nanoparticles 25 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O

Back to Previous Page

Iron oxide (II,III), nanoparticles 25 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O

ITEM#: 3042-9000941ML

MFR#: 900094-1ML

See More Details

Iron oxide (II,III), nanoparticles 25 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O

Product Name	Description	Item#	QTY
Iron oxide (II,III), nanoparticles 15 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O	Iron oxide (II,III), nanoparticles 15 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O	3042-9000921ML	EA
Iron oxide (II,III), nanoparticles 20 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O	Iron oxide (II,III), nanoparticles 20 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O	3042-9000931ML	EA
Iron oxide (II,III), nanoparticles 10 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O	Iron oxide (II,III), nanoparticles 10 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O	3042-9000911ML	EA
Iron oxide (II,III), nanoparticles 30 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O	Recent docking studies highlight the potential interaction of iron oxide (II,III) nanoparticles (IONPs) with the SARS-CoV-2 spike protein receptor binding domain. This may target viral entry in host cells and also render virions inactive.	3042-9001481ML	EA
Iron oxide (II,III), nanoparticles 25 nm avg. part. size (TEM), PEG functionalized, 1 mg/mL in H2O	Iron oxide (II,III), nanoparticles 25 nm avg. part. size (TEM), PEG functionalized, 1 mg/mL in H2O	3042-90002710ML	EA